About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 572821, 11 pages
http://dx.doi.org/10.1155/2012/572821
Review Article

Insights and Hopes in Umbilical Cord Blood Stem Cell Transplantations

1Department of Immunology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad 381351698, Iran
2Center of Hematology and Hemotherapy (Hemocentro), School of Medicine and Medical Sciences (FCM), University of Campinas (UNICAMP), Campinas, 13083-878 Sao Paulo, SP, Brazil
3Department of Biomedicine and Biotechnology, Fluorotronics, Inc., San Diego, CA 92081, USA
4Hematology Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran 14114, Iran
5Cell Therapy Research Institue, 69330 Meyzieu, Lyon, France
6Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 1411713116, Iran

Received 5 August 2012; Accepted 8 October 2012

Academic Editor: Ali Khraibi

Copyright © 2012 Somayeh Shahrokhi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Halbrecht, “Transfusion with placental blood,” The Lancet, vol. 233, no. 6022, pp. 202–203, 1939. View at Scopus
  2. M. Ende and N. Ende, “Hematopoietic transplantation by means of fetal (cord) blood. A new method.,” Virginia Medical Monthly, vol. 99, no. 3, pp. 276–280, 1972. View at Scopus
  3. E. Gluckman, H. E. Broxmeyer, A. D. Auerbach et al., “Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling,” New England Journal of Medicine, vol. 321, no. 17, pp. 1174–1178, 1989. View at Scopus
  4. H. E. Broxmeyer and F. O. Smith, “Cord blood hematopoietic cell transplantation,” in Thomas' Hematopoietic Cell Transplantation, pp. 559–576, Wiley-Blackwell, Malden, Mass, USA, 2009.
  5. R. Hough and V. Rocha, “Transplant outcomes in acute leukemia (II),” Seminars in Hematology, vol. 47, no. 1, pp. 51–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. L. MacMillan, M. C. Walters, and E. Gluckman, “Transplant outcomes in bone marrow failure syndromes and hemoglobinopathies,” Seminars in Hematology, vol. 47, no. 1, pp. 37–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. E. Wagner, N. A. Kernan, M. Steinbuch, H. E. Broxmeyer, and E. Gluckman, “Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease,” The Lancet, vol. 346, no. 8969, pp. 214–219, 1995. View at Scopus
  8. E. Gluckman, V. Rocha, A. Boyer-Chammard, et al., “Outcome of cord-blood transplantation from related and unrelated donors. Eurocord transplant group and the European blood and marrow transplantation group,” New England Journal of Medicine, vol. 337, no. 6, pp. 373–381, 1997. View at Publisher · View at Google Scholar
  9. F. Locatelli, V. Rocha, C. Chastang et al., “Factors associated with outcome after cord blood transplantation in children with acute leukemia,” Blood, vol. 93, no. 11, pp. 3662–3671, 1999. View at Scopus
  10. V. Rocha and E. Gluckman, “Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors,” British Journal of Haematology, vol. 147, no. 2, pp. 262–274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. H. E. Broxmeyer, “Umbilical cord transplantation: epilogue,” Seminars in Hematology, vol. 47, no. 1, pp. 97–103, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Rocha and H. E. Broxmeyer, “New approaches for improving engraftment after cord blood transplantation.,” Biology of Blood and Marrow Transplantation, vol. 16, supplement 1, pp. S126–S132, 2010. View at Scopus
  13. G. Cohen, S. L. Carter, K. I. Weinberg et al., “Antigen-specific T-lymphocyte function after cord blood transplantation,” Biology of Blood and Marrow Transplantation, vol. 12, no. 12, pp. 1335–1342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Rocha and F. Locatelli, “Searching for alternative hematopoietic stem cell donors for pediatric patients,” Bone Marrow Transplantation, vol. 41, no. 2, pp. 207–214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Eapen, P. Rubinstein, M. J. Zhang et al., “Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study,” The Lancet, vol. 369, no. 9577, pp. 1947–1954, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. V. K. Prasad and J. Kurtzberg, “Umbilical cord blood transplantation for non-malignant diseases,” Bone Marrow Transplantation, vol. 44, no. 10, pp. 643–651, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Gluckman, V. Rocha, I. Ionescu et al., “Results of unrelated cord blood transplant in Fanconi anemia patients: risk factor analysis for engraftment and survival,” Biology of Blood and Marrow Transplantation, vol. 13, no. 9, pp. 1073–1082, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Willasch, W. Hoelle, H. Kreyenberg et al., “Outcome of allogeneic stem cell transplantation in children with non-malignant diseases,” Haematologica, vol. 91, no. 6, pp. 788–794, 2006. View at Scopus
  19. G. Michel, V. Rocha, S. Chevret et al., “Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis,” Blood, vol. 102, no. 13, pp. 4290–4297, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Rubinstein, C. Carrier, A. Scaradavou et al., “Outcomes among 562 recipients of placental-blood transplants from unrelated donors,” New England Journal of Medicine, vol. 339, no. 22, pp. 1565–1577, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. J. E. Wagner, J. N. Barker, T. E. DeFor et al., “Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival,” Blood, vol. 100, no. 5, pp. 1611–1618, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Rocha, G. Sanz, and E. Gluckman, “Umbilical cord blood transplantation,” Current Opinion in Hematology, vol. 11, no. 6, pp. 375–385, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Gluckman, V. Rocha, W. Arcese et al., “Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice,” Experimental Hematology, vol. 32, no. 4, pp. 397–407, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. C. G. Brunstein, J. N. Barker, D. J. Weisdorf et al., “Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease,” Blood, vol. 110, no. 8, pp. 3064–3070, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. J. N. Barker, D. J. Weisdorf, T. E. DeFor et al., “Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy,” Blood, vol. 105, no. 3, pp. 1343–1347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Delaney, M. Z. Ratajczak, and M. J. Laughlin, “Strategies to enhance umbilical cord blood stem cell engraftment in adult patients,” Expert Review of Hematology, vol. 3, no. 3, pp. 273–283, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Stanevsky, A. Shimoni, R. Yerushalmi, and A. Nagler, “Cord blood stem cells for hematopoietic transplantation,” Stem Cell Reviews and Reports, vol. 7, no. 2, pp. 425–433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. J. A. Gutman, S. R. Riddell, S. McGoldrick, and C. Delaney, “Double unit cord blood transplantation: who wins-and why do we care?” Chimerism, vol. 1, no. 1, pp. 21–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Rocha, J. E. Wagner, K. A. Sobocinski et al., “Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling,” New England Journal of Medicine, vol. 342, no. 25, pp. 1846–1854, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. H. M. Lazarus, “Acute leukemia in adults: novel allogeneic transplant strategies,” Hematology, vol. 17, supplement 1, pp. 47–51, 2012.
  31. M.-J. Zhang, S. M. Davies, B. M. Camitta, B. Logan, K. Tiedemann, and M. Eapen, “Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia,” Biology of Blood and Marrow Transplantation, vol. 18, no. 8, pp. 1204–1210, 2012. View at Publisher · View at Google Scholar
  32. L. E. Perez, “Outcomes from unrelated donor hematopoietic stem cell transplantation,” Cancer Control, vol. 18, no. 4, pp. 216–221, 2011.
  33. M. Eapen, V. Rocha, G. Sanz et al., “Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis,” The Lancet Oncology, vol. 11, no. 7, pp. 653–660, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. J. Laughlin, M. Eapen, P. Rubinstein et al., “Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia,” New England Journal of Medicine, vol. 351, no. 22, pp. 2265–2275, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Kurtzberg, M. Laughlin, M. L. Graham et al., “Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients,” New England Journal of Medicine, vol. 335, no. 3, pp. 157–166, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Ghavamzadeh, K. Alimoghaddam, A. Naderi et al., “Outcome of related and unrelated cord-blood transplantation in children at hematopoietic stem cell transplantation research center of Shariati Hospital,” International Journal of Hematology-Oncology and Stem Cell Research, vol. 3, no. 1, pp. 17–20, 2009. View at Scopus
  37. J. N. Barker, T. P. Krepski, T. E. DeFor, S. M. Davies, J. E. Wagner, and D. J. Weisdorf, “Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow,” Biology of Blood and Marrow Transplantation, vol. 8, no. 5, pp. 257–260, 2002. View at Scopus
  38. H. E. Broxmeyer, E. Gluckman, A. Auerbach et al., “Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells,” International Journal of Cell Cloning, vol. 8, supplement 1, pp. 76–91, 1990. View at Scopus
  39. S. J. Deacock, A. P. Schwarer, J. Bridge, J. R. Batchelor, J. M. Goldman, and R. I. Lechler, “Evidence that umbilical cord blood contains a higher frequency of HLA class II-specific alloreactive T cells than adult peripheral blood: a limiting dilution analysis,” Transplantation, vol. 53, no. 5, pp. 1128–1134, 1992. View at Scopus
  40. M. G. Roncarolo, M. Bigler, E. Ciuti, S. Martino, and P. A. Tovo, “Immune responses by cord blood cells,” Blood Cells, vol. 20, no. 2-3, pp. 573–586, 1994. View at Scopus
  41. A. Bensussan, E. Gluckman, S. El Marsafy et al., “BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 19, pp. 9136–9140, 1994. View at Publisher · View at Google Scholar · View at Scopus
  42. X. J. Huang, D. H. Liu, K. Y. Liu et al., “Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation,” Biology of Blood and Marrow Transplantation, vol. 15, no. 2, pp. 257–265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Ciceri, M. Labopin, F. Aversa et al., “A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation,” Blood, vol. 112, no. 9, pp. 3574–3581, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Aversa, A. Terenzi, A. Tabilio et al., “Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse,” Journal of Clinical Oncology, vol. 23, no. 15, pp. 3447–3454, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Naparstek, M. Delukina, R. Or et al., “Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies,” Experimental Hematology, vol. 27, no. 7, pp. 1210–1218, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. T. B. Prigozhina, O. Gurevitch, and S. Slavin, “Nonmyeloablative conditioning to induce bilateral tolerance after allogeneic bone marrow transplantation in mice,” Experimental Hematology, vol. 27, no. 10, pp. 1503–1510, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Ruggeri, A. Mancusi, M. Capanni et al., “Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value,” Blood, vol. 110, no. 1, pp. 433–440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Perruccio, A. Tosti, E. Burchielli et al., “Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation,” Blood, vol. 106, no. 13, pp. 4397–4406, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. C. P. McGuckin, N. Forraz, M. O. Baradez et al., “Production of stem cells with embryonic characteristics from human umbilical cord blood,” Cell Proliferation, vol. 38, no. 4, pp. 245–255, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Basford, N. Forraz, and C. McGuckin, “Optimized multiparametric immunophenotyping of umbilical cord blood cells by flow cytometry,” Nature Protocols, vol. 5, no. 7, pp. 1337–1346, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. C. P. McGuckin, C. Basford, K. Hanger, S. Habibollah, and N. Forraz, “Cord blood revelations: the importance of being a first born girl, big, on time and to a young mother!,” Early Human Development, vol. 83, no. 12, pp. 733–741, 2007. View at Publisher · View at Google Scholar
  52. F. Mancinelli, A. Tamburini, A. Spagnoli et al., “Optimizing umbilical cord blood collection: impact of obstetric factors versus quality of cord blood units,” Transplantation Proceedings, vol. 38, no. 4, pp. 1174–1176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. C. P. McGuckin, D. Pearce, N. Forraz, J. A. Tooze, S. M. Watt, and R. Pettengell, “Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow,” European Journal of Haematology, vol. 71, no. 5, pp. 341–350, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. V. Tommiska, K. Heinonen, S. Ikonen et al., “A national short-term follow-Up study of extremely low birth weight infants born in Finland in 1996-1997.,” Pediatrics, vol. 107, no. 1, p. E2, 2001. View at Scopus
  55. B. Adkins, “T-cell function in newborn mice and humans,” Immunology Today, vol. 20, no. 7, pp. 330–335, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Li, D. R. Barreda, Y. A. Zhang et al., “B lymphocytes from early vertebrates have potent phagocytic and microbicidal abilities,” Nature Immunology, vol. 7, no. 10, pp. 1116–1124, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Liao, M. B. Geyer, A. J. Yang, and M. S. Cairo, “Cord blood transplantation and stem cell regenerative potential,” Experimental Hematology, vol. 39, no. 4, pp. 393–412, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. S. S. Tung, S. Parmar, S. N. Robinson, M. De Lima, and E. J. Shpallemail, “Ex vivo expansion of umbilical cord blood for transplantation,” Best Practice & Research Clinical Haematology, vol. 23, no. 2, pp. 245–257, 2010. View at Publisher · View at Google Scholar
  59. I. McNiece, D. Kubegov, P. Kerzic, E. J. Shpall, and S. Gross, “Increased expansion and differentiation of cord blood products using a two-step expansion culture,” Experimental Hematology, vol. 28, no. 10, pp. 1181–1186, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. E. J. Shpall, R. Quinones, R. Giller et al., “Transplantation of ex vivo expanded cord blood,” Biology of Blood and Marrow Transplantation, vol. 8, no. 7, pp. 368–376, 2002. View at Scopus
  61. M. Ebtekar, S. Shahrokhi, and K. Alimoghaddam, Characteristics of Cord Blood Stem Cells: Role of Substance P, (SP) and Calcitonin Gene-Related Peptide (CGRP), Stem Cells and Cancer Stem Cells, vol. 2, Springer Netherlands, Heidelberg, Germany, 2012.
  62. S. Shahrokhi, M. Ebtekar, K. Alimoghaddam et al., “Substance P and calcitonin gene-related neuropeptides as novel growth factors for ex vivo expansion of cord blood CD34+ hematopoietic stem cells,” Growth Factors, vol. 28, no. 1, pp. 66–73, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Rameshwar, D. Ganea, and P. Gascon, “In vitro stimulatory effect of Substance P on hematopoiesis,” Blood, vol. 81, no. 2, pp. 391–398, 1993. View at Scopus
  64. D. McKenna and J. Sheth, “Umbilical cord blood: current status and promise for the future,” Indian Journal of Medical Research, vol. 134, pp. 261–269, 2011.
  65. T. Peled, J. Mandel, R. N. Goudsmid et al., “Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine,” Cytotherapy, vol. 6, no. 4, pp. 344–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Delaney, S. Heimfeld, C. Brashem-Stein, H. Voorhies, R. L. Manger, and I. D. Bernstein, “Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution,” Nature Medicine, vol. 16, no. 2, pp. 232–236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. C. M. Verfaillie, “Adhesion receptors as regulators of the hematopoietic process,” Blood, vol. 92, no. 8, pp. 2609–2612, 1998. View at Scopus
  68. S. Shahrokhi, M. Ebtekar, K. Alimoghaddam et al., “Communication of substance P, calcitonin-gene-related neuropeptides and chemokine receptor 4 (CXCR4) in cord blood hematopoietic stem cells,” Neuropeptides, vol. 44, no. 5, pp. 385–389, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Shahrokhi, K. Alimoghaddam, M. Ebtekar et al., “Effects of neuropeptide substance P on the expression of adhesion molecules in cord blood hematopoietic stem cells,” Annals of Hematology, vol. 89, no. 12, pp. 1197–1205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. M. J. Laughlin, J. Barker, B. Bambach et al., “Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors,” New England Journal of Medicine, vol. 344, no. 24, pp. 1815–1822, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. J. N. Barker, S. M. Davies, T. DeFor, N. K. C. Ramsay, D. J. Weisdorf, and J. E. Wagner, “Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis,” Blood, vol. 97, no. 10, pp. 2957–2961, 2001. View at Publisher · View at Google Scholar · View at Scopus
  72. F. O. Pinto and I. Roberts, “Cord blood stem cell transplantation for haemoglobinopathies,” British Journal of Haematology, vol. 141, no. 3, pp. 309–324, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. F. Locatelli, V. Rocha, W. Reed et al., “Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease,” Blood, vol. 101, no. 6, pp. 2137–2143, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. T. V. Adamkiewicz, P. Szabolcs, A. Haight et al., “Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience,” Pediatric Transplantation, vol. 11, no. 6, pp. 641–644, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. J. E. Wagner, J. Rosenthal, R. Sweetman et al., “Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft- versus-host disease,” Blood, vol. 88, no. 3, pp. 795–802, 1996. View at Scopus
  76. J. Kurtzberg, M. Graham, J. Casey, J. Olson, C. E. Stevens, and P. Rubinstein, “The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation,” Blood Cells, vol. 20, no. 2-3, pp. 275–284, 1994. View at Scopus
  77. A. A. Maschan, E. V. Skorobogatova, E. V. Samotchatova et al., “A successful cord blood transplant in a child with second accelerated phase chronic myeloid leukemia following lymphoid blast crisis,” Bone Marrow Transplantation, vol. 25, no. 2, pp. 213–215, 2000. View at Scopus
  78. A. L. Pecora, P. Stiff, A. Jennis et al., “Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood,” Bone Marrow Transplantation, vol. 25, no. 7, pp. 797–799, 2000. View at Scopus
  79. C. Brunstein, D. Setubal, T. DeFor, et al., “Umbilical cord blood transplantation for adult patients with chronic myeloid leukemia,” Biology of Blood and Marrow Transplantation, vol. 13, no. 2, p. 84, 2007.
  80. G. F. Sanz, S. Saavedra, C. Jiménez et al., “Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution,” Bone Marrow Transplantation, vol. 27, no. 7, pp. 693–701, 2001. View at Publisher · View at Google Scholar · View at Scopus
  81. J. Sanz, P. Montesinos, S. Saavedra et al., “Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia,” Biology of Blood and Marrow Transplantation, vol. 16, no. 11, pp. 1589–1595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Sato, J. Ooi, S. Takahashi et al., “Unrelated cord blood transplantation after myeloablative conditioning in adults with advanced myelodysplastic syndromes,” Bone Marrow Transplantation, vol. 46, no. 2, pp. 257–261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. E. D. Warlick, A. Cioc, T. DeFor, M. Dolan, and D. Weisdorf, “Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden,” Biology of Blood and Marrow Transplantation, vol. 15, no. 1, pp. 30–38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. D. A. Wall, S. L. Carter, N. A. Kernan et al., “Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience,” Biology of Blood and Marrow Transplantation, vol. 11, no. 8, pp. 637–646, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Kurtzberg, V. K. Prasad, S. L. Carter et al., “Results of the cord blood transplantation study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies,” Blood, vol. 112, no. 10, pp. 4318–4327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. V. Rocha, M. Labopin, G. Sanz et al., “Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia,” New England Journal of Medicine, vol. 351, no. 22, pp. 2276–2285, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Takahashi, J. Ooi, A. Tomonari et al., “Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen,” Blood, vol. 109, no. 3, pp. 1322–1330, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. P. Kumar, T. E. Defor, C. Brunstein et al., “Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival,” Biology of Blood and Marrow Transplantation, vol. 14, no. 12, pp. 1394–1400, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. M. B. Tomblyn, M. Arora, K. S. Baker et al., “Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome,” Journal of Clinical Oncology, vol. 27, no. 22, pp. 3634–3641, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. Y. Atsuta, R. Suzuki, T. Nagamura-Inoue et al., “Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia,” Blood, vol. 113, no. 8, pp. 1631–1638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. C. G. Brunstein, J. A. Gutman, D. J. Weisdorf et al., “Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood,” Blood, vol. 116, no. 22, pp. 4693–4699, 2010. View at Publisher · View at Google Scholar · View at Scopus
  92. J. Ooi, T. Iseki, S. Takahashi et al., “Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia,” Blood, vol. 103, no. 2, pp. 489–491, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. J. Sanz, M. A. Sanz, S. Saavedra et al., “Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia,” Biology of Blood and Marrow Transplantation, vol. 16, no. 1, pp. 86–94, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. K. K. Ballen, T. R. Spitzer, B. Y. Yeap et al., “Double unrelated reduced-intensity umbilical cord blood transplantation in adults,” Biology of Blood and Marrow Transplantation, vol. 13, no. 1, pp. 82–89, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. E. D. Thomas, C. D. Buckner, and J. E. Sanders, “Marrow transplantation for thalassaemia,” The Lancet, vol. 2, no. 8292, pp. 227–229, 1982. View at Scopus
  96. T. H. Jaing, I. J. Hung, C. P. Yang, S. H. Chen, C. F. Sun, and R. Chow, “Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with β-thalassemia major,” Biology of Blood and Marrow Transplantation, vol. 11, no. 5, pp. 349–353, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. T. H. Jaing, C. P. Yang, I. J. Hung, S. H. Chen, C. F. Sun, and R. Chow, “Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia,” Bone Marrow Transplantation, vol. 40, no. 4, pp. 307–311, 2007. View at Publisher · View at Google Scholar · View at Scopus
  98. T. H. Jaing, P. Tan, J. Rosenthal, et al., “166: unrelated cord blood transplantation (UCBT) for transfusion-dependent thalassemia-a retrospective audited analysis of 41 consecutive patients,” Biology of Blood and Marrow Transplantation, vol. 13, no. 2, p. 62, 2007.